← Leaderboards
Andrei Goga
University Of California San Francisco
$13,440,540
Attributed
$16,558,858
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,558,858 · 10
By mechanism
R01$8,620,712 · 5
U01$3,561,819 · 2
T32$3,371,929 · 1
K08$635,610 · 1
P30$368,788 · 1
Top collaborators
- Zev Jordan Gartner6 shared
- Mark A Labarge6 shared
- Matthew W. Thomson6 shared
- Nimmi Ramanujam2 shared
- Paul T Spellman1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Roger A Cooke$6,744,839
- Zena Werb$33,582,689
- Gerald R Cunha$2,630,951
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsNeoplastic CellCellsTumorIn VivoProgramsInnovationMolecularPathway InteractionsMalignant Breast NeoplasmLeadCell DeathOncogenesNovel TherapeuticsMediatingBreastTissuesNeoplasm MetastasisGeneticOncogenicMouse ModelOverexpressionResponseGrowth
Grant awards (39)
Development of CapCell Scope for Metabolic Imaging of Tissue Heterogeneity and Therapy Response$591,384
R01 · FY2025 · EB
Understanding CDK1 Function and Cancer Vulnerabilities$484,012
R01 · FY2025 · CA · contact PI
Breast Oncology Program$185,527
P30 · FY2025 · CA · contact PI
Molecular and Cellular Mechanisms in Cancer$672,808
T32 · FY2024 · CA · contact PI
Development of CapCell Scope for Metabolic Imaging of Tissue Heterogeneity and Therapy Response$608,401
R01 · FY2024 · EB
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization$548,840
U01 · FY2024 · CA
Understanding CDK1 Function and Cancer Vulnerabilities$459,739
R01 · FY2024 · CA · contact PI
Breast Oncology Program$183,261
P30 · FY2024 · CA · contact PI
Molecular and Cellular Mechanisms in Cancer$558,696
T32 · FY2023 · CA · contact PI
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization$487,998
U01 · FY2023 · CA
Understanding CDK1 Function and Cancer Vulnerabilities$483,857
R01 · FY2023 · CA · contact PI
A single cell assay for tissue activity$161,345
U01 · FY2023 · CA
Molecular and Cellular Mechanisms in Cancer$611,058
T32 · FY2022 · CA · contact PI
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization$566,166
U01 · FY2022 · CA
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors$362,043
R01 · FY2022 · CA · contact PI
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization$577,726
U01 · FY2021 · CA
Molecular and Cellular Mechanisms in Cancer$442,047
T32 · FY2021 · CA · contact PI
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors$369,431
R01 · FY2021 · CA · contact PI
Integrative approach to heterogeneity in breast cancer metastasis$611,755
U01 · FY2020 · CA · contact PI
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization$607,989
U01 · FY2020 · CA
Molecular and Cellular Mechanisms in Cancer$571,532
T32 · FY2020 · CA · contact PI
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors$369,431
R01 · FY2020 · CA · contact PI
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors$356,129
R01 · FY2019 · CA · contact PI
Molecular and Cellular Mechanisms in Cancer$515,788
T32 · FY2018 · CA · contact PI
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors$366,000
R01 · FY2018 · CA · contact PI
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)$605,208
R01 · FY2015 · CA · contact PI
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)$592,994
R01 · FY2014 · CA · contact PI
Targeting the MYC Oncogene with CDK Inhibitors$341,740
R01 · FY2014 · CA · contact PI
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)$573,631
R01 · FY2013 · CA · contact PI
Targeting the MYC Oncogene with CDK Inhibitors$335,610
R01 · FY2013 · CA · contact PI
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)$610,974
R01 · FY2012 · CA · contact PI
Targeting the MYC Oncogene with CDK Inhibitors$361,902
R01 · FY2012 · CA · contact PI
Targeting the MYC Oncogene with CDK Inhibitors$366,915
R01 · FY2011 · CA · contact PI
Targeting the MYC Oncogene with CDK Inhibitors$381,311
R01 · FY2010 · CA · contact PI
CDK Inhibition in Cancer$127,170
K08 · FY2009 · CA · contact PI
CDK Inhibition in Cancer$127,170
K08 · FY2008 · CA · contact PI
CDK Inhibition in Cancer$127,170
K08 · FY2007 · CA · contact PI
CDK Inhibition in Cancer$127,170
K08 · FY2006 · CA · contact PI
CDK Inhibition in Cancer$126,930
K08 · FY2005 · CA